Viveve Medical developed and commercialized medical devices for women's intimate health, including cryogen-cooled monopolar radiofrequency (CMRF) systems for vaginal health and nonsurgical treatment research for stress urinary incontinence
Viveve Medical developed and commercialized medical devices for women's intimate health, including cryogen-cooled monopolar radiofrequency (CMRF) systems for vaginal health and nonsurgical treatment research for stress urinary incontinence. Its products were used in clinical settings, and it also distributed FDA-cleared incontinence and pelvic-floor devices. In 2023, InMode acquired Viveve's intellectual property assets.